GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Health Industries Holdings Inc (OTCPK:CHHE) » Definitions » PB Ratio

China Health Industries Holdings (China Health Industries Holdings) PB Ratio : (As of May. 23, 2024)


View and export this data going back to 2006. Start your Free Trial

What is China Health Industries Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-23), China Health Industries Holdings's share price is $1.92. China Health Industries Holdings's Book Value per Share for the quarter that ended in Dec. 2023 was $-0.04. Hence, China Health Industries Holdings's PB Ratio of today is .

The historical rank and industry rank for China Health Industries Holdings's PB Ratio or its related term are showing as below:

During the past 13 years, China Health Industries Holdings's highest PB Ratio was 5.03. The lowest was 0.02. And the median was 0.35.

CHHE's PB Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.02
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, China Health Industries Holdings's average Book Value Per Share Growth Rate was -105.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -0.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 3.10% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 1.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of China Health Industries Holdings was 129.90% per year. The lowest was -53.60% per year. And the median was -0.65% per year.

Back to Basics: PB Ratio


China Health Industries Holdings PB Ratio Historical Data

The historical data trend for China Health Industries Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Industries Holdings PB Ratio Chart

China Health Industries Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.32 0.58 0.30 0.02 0.37

China Health Industries Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.22 0.37 5.08 -

Competitive Comparison of China Health Industries Holdings's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Health Industries Holdings's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where China Health Industries Holdings's PB Ratio falls into.



China Health Industries Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

China Health Industries Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=1.92/-0.035
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


China Health Industries Holdings  (OTCPK:CHHE) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


China Health Industries Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of China Health Industries Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China Health Industries Holdings (China Health Industries Holdings) Business Description

Traded in Other Exchanges
N/A
Address
3199-1 Longxiang Road, Songbei District, Heilongjiang Province, Harbin, CHN, 150028
China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.
Executives
Sun Xin director, 10 percent owner, officer: CEO, CFO and Treasurer NO 168 BINBEI STREET, SONBEI DISTRICT, HARBIN, HEI LONG JIANG F4 150000
Hall E Ewing director, officer: Secretary 2737 W BASELINE RD 22, TEMPE AZ 85283
Jack C Robinson director 16304 E COUNTRY SHADOW CT, LILBEAT AZ 85297
Teri S Foster director 402 CANDOVER COURT, KATY TX 77450
Brian Lee Hahn director, officer: COO 422 LAMONT TERRACE, BUFFALO GROVE IL 60089
Dennis Mckee 10 percent owner 3522 DOHERTY PLACE, KATY TX 77449
Thomas Allen Bontems 10 percent owner, officer: President, CEO, CFO and, other: Secretary 1808 S. 1ST AVENUE, PHONEIX AZ 85003

China Health Industries Holdings (China Health Industries Holdings) Headlines

No Headlines